Flanagan, Kenneth <br/><br/>
Local delivery of recombinant vaccinia virus expressing secondary lymphoid chemokine (SLC) results in a CD4 T-cell dependent antitumor response.  [electronic resource] 

 -  Vaccine  Jul 2004 
 - 2894-903 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0264-410X 
<br/><br/><label>Standard No.: </label>10.1016/j.vaccine.2003.12.021  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Blotting, Southern<br/>Blotting, Western<br/>CD4-Positive T-Lymphocytes--immunology<br/>CD8-Positive T-Lymphocytes--immunology<br/>Cancer Vaccines--genetics<br/>Cell Line<br/>Chemokine CCL21<br/>Chemokines, CC--biosynthesis<br/>Chemotaxis, Leukocyte<br/>Colonic Neoplasms--immunology<br/>Cytotoxicity, Immunologic<br/>Dendritic Cells--immunology<br/>Female<br/>Flow Cytometry<br/>Immunohistochemistry<br/>Mice<br/>Mice, Inbred BALB C<br/>Microinjections<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>T-Lymphocytes, Cytotoxic--immunology<br/>T-Lymphocytes, Regulatory--immunology<br/>Vaccines, Synthetic--administration & dosage<br/>Vaccinia virus--genetics<br/>Viral Vaccines--adverse effects